• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光学纯左卡巴斯汀(H₁受体拮抗剂)的实用可持续合成。

Practical and Sustainable Synthesis of Optically Pure Levocabastine, a H₁ Receptor Antagonist.

机构信息

College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea.

Department of Synthetic Chemistry, Chong Kun Dang Research Institute, 315-20, Dongbaekjukjeon-daero, Giheung-gu, Yongin-si 16995, Gyeonggi-do, Korea.

出版信息

Molecules. 2017 Nov 15;22(11):1971. doi: 10.3390/molecules22111971.

DOI:10.3390/molecules22111971
PMID:29140307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6150193/
Abstract

A practical and sustainable method for the synthesis of levocabastine hydrochloride (), a H₁ receptor antagonist for the treatment of allergic conjunctivitis, that can be applied to the industrial production of the compound has been developed. Substantial improvements over the previously reported procedure are achieved via efficient preparation of an optically active key intermediate () without chiral resolution and with a more effective detosylation, which complements the previous procedure. Notably, our process requires no chromatographic purification and provides levocabastine hydrochloride in greater than 99.5% purity in a 14.2% overall yield.

摘要

已开发出一种实用且可持续的方法来合成盐酸左卡巴斯汀(),这是一种用于治疗过敏性结膜炎的 H₁受体拮抗剂,可以应用于该化合物的工业生产。与之前报道的方法相比,通过有效制备光学活性关键中间体()而无需手性拆分且脱酯化更有效,从而实现了实质性改进,这补充了之前的方法。值得注意的是,我们的工艺不需要进行色谱纯化,并且以 14.2%的总收率提供了超过 99.5%纯度的盐酸左卡巴斯汀。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31cc/6150193/7afb07ccb737/molecules-22-01971-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31cc/6150193/cc8ec31521f8/molecules-22-01971-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31cc/6150193/facef7ea466d/molecules-22-01971-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31cc/6150193/6636f80ebbef/molecules-22-01971-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31cc/6150193/7cb160d54bd1/molecules-22-01971-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31cc/6150193/7afb07ccb737/molecules-22-01971-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31cc/6150193/cc8ec31521f8/molecules-22-01971-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31cc/6150193/facef7ea466d/molecules-22-01971-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31cc/6150193/6636f80ebbef/molecules-22-01971-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31cc/6150193/7cb160d54bd1/molecules-22-01971-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31cc/6150193/7afb07ccb737/molecules-22-01971-sch004.jpg

相似文献

1
Practical and Sustainable Synthesis of Optically Pure Levocabastine, a H₁ Receptor Antagonist.光学纯左卡巴斯汀(H₁受体拮抗剂)的实用可持续合成。
Molecules. 2017 Nov 15;22(11):1971. doi: 10.3390/molecules22111971.
2
The early efficacy of topical levocabastine in patients with allergic conjunctivitis.局部用左卡巴斯汀治疗过敏性结膜炎患者的早期疗效。
Allergol Int. 2006 Sep;55(3):301-3. doi: 10.2332/allergolint.55.301.
3
Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.左卡巴斯汀。其在过敏性鼻炎和结膜炎局部治疗中的药理学、临床疗效及耐受性的最新进展。
Drugs. 1995 Dec;50(6):1032-49. doi: 10.2165/00003495-199550060-00009.
4
Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis.左卡巴斯汀。对其作为局部抗组胺药在变应性鼻炎和结膜炎中的药理特性及治疗潜力的综述。
Drugs. 1991 Feb;41(2):202-24. doi: 10.2165/00003495-199141020-00006.
5
[Levocabastine--a new antihistaminic for local treatment].
Ugeskr Laeger. 1993 Jun 28;155(26):2070-3.
6
Efficacy of levocabastine hydrochloride ophthalmic suspension in the conjunctival allergen challenge test in Japanese subjects with seasonal allergic conjunctivitis.盐酸左卡巴斯汀眼用混悬液在日本季节性过敏性结膜炎患者结膜过敏原激发试验中的疗效。
Allergol Int. 2006 Jun;55(2):157-65. doi: 10.2332/allergolint.55.157.
7
Synthesis, biological evaluation, and quantitative structure-activity relationship analysis of [beta-(Aroylamino)ethyl]piperazines and -piperidines and [2-[(Arylamino)carbonyl]ethyl]piperazines, -pyrazinopyridoindoles, and -pyrazinoisoquinolines. A new class of potent H1 antagonists.[β-(芳酰氨基)乙基]哌嗪和哌啶以及[2-[(芳氨基)羰基]乙基]哌嗪、吡嗪并吡啶吲哚和吡嗪异喹啉的合成、生物学评价及定量构效关系分析。一类新型强效H1拮抗剂。
J Med Chem. 1990 Nov;33(11):2970-6. doi: 10.1021/jm00173a011.
8
Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.左卡巴斯汀:一种治疗儿童过敏性鼻结膜炎的新局部用药方法。
Rhinol Suppl. 1992 Sep;13:39-49.
9
Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.局部用左卡巴斯汀对常年性鼻炎患者鼻对变应原激发的反应及鼻高反应性的影响。
Ann Allergy Asthma Immunol. 1995 Sep;75(3):261-6.
10
Dual antagonists of platelet activating factor and histamine. Identification of structural requirements for dual activity of N-Acyl-4-(5,6-dihydro-11H-benzo [5,6]cyclohepta-[1,2-b]pyridin-11-ylidene)piperidines.血小板活化因子和组胺的双重拮抗剂。N-酰基-4-(5,6-二氢-11H-苯并[5,6]环庚并[1,2-b]吡啶-11-亚基)哌啶双重活性结构要求的鉴定。
J Med Chem. 1991 Jan;34(1):457-61. doi: 10.1021/jm00105a069.

本文引用的文献

1
Nucleophilic substitution reaction at the nitrogen of arylsulfonamides with phosphide anion.芳基磺酰胺氮上的亲核取代反应与膦阴离子。
J Am Chem Soc. 2012 Nov 28;134(47):19358-61. doi: 10.1021/ja309642r. Epub 2012 Nov 14.
2
Ophthalmic antihistamines and H1-H4 receptors.眼科抗组胺药和 H1-H4 受体。
Curr Opin Allergy Clin Immunol. 2012 Oct;12(5):510-6. doi: 10.1097/ACI.0b013e328357d3ba.
3
Ti(O-i-Pr)4/Me3SiCl/Mg-mediated reductive cleavage of sulfonamides and sulfonates to amines and alcohols.四异丙氧基钛/三甲基氯硅烷/镁介导的磺酰胺和磺酸盐的还原裂解为胺和醇。
Org Lett. 2011 May 20;13(10):2626-9. doi: 10.1021/ol200740r. Epub 2011 Apr 21.
4
Topical levocabastine-a review of therapeutic efficacy compared with topical sodium cromoglycate and oral terfenadine on days with high pollen counts.局部左旋西替利嗪——在花粉计数高的日子里,与局部色甘酸钠和口服特非那定相比的疗效评价。
Mediators Inflamm. 1995;4(7):S21-5. doi: 10.1155/S0962935195000809.
5
Efficacy and tolerability of levocabastine and azelastine nasal sprays for the treatment of allergic rhinitis.左旋卡巴斯汀和氮卓斯汀鼻喷雾剂治疗过敏性鼻炎的疗效和耐受性。
Mediators Inflamm. 1995;4(7):S11-5. doi: 10.1155/S0962935195000780.
6
Histamine in the immune regulation of allergic inflammation.组胺在过敏性炎症的免疫调节中。
J Allergy Clin Immunol. 2003 Jul;112(1):15-22. doi: 10.1067/mai.2003.1585.
7
Trends in histamine research: new functions during immune responses and hematopoiesis.组胺研究的趋势:免疫反应和造血过程中的新功能。
Trends Immunol. 2002 May;23(5):255-63. doi: 10.1016/s1471-4906(02)02215-9.
8
H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.H1抗组胺药:反向激动作用、抗炎作用及心脏效应。
Clin Exp Allergy. 2002 Apr;32(4):489-98. doi: 10.1046/j.0954-7894.2002.01314.x.
9
Histamine H(1)-receptor activation of nuclear factor-kappa B: roles for G beta gamma- and G alpha(q/11)-subunits in constitutive and agonist-mediated signaling.
Mol Pharmacol. 2001 Nov;60(5):1133-42. doi: 10.1124/mol.60.5.1133.
10
Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes.一种优先在白细胞中表达的新型组胺受体的分子克隆与特性分析。
J Biol Chem. 2000 Nov 24;275(47):36781-6. doi: 10.1074/jbc.M006480200.